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Objectives: 1) to examine whether areal bone mineral density (aBMD) differs between 
metabolically healthy (MHO) and unhealthy (MUO) overweight/obese children, and 2) to 
examine the role of moderate-to-vigorous physical activity (MVPA), and cardiorespiratory 
fitness (CRF) in this association. Methods: a cross-sectional study was developed in 188 
overweight/obese children (10.4 ± 1.2y) from the ActiveBrains and EFIGRO studies. 
Participants were classified as MHO or MUO based on Jolliffe and Janssen´s metabolic 
syndrome cut-off points for triglycerides, glucose, high-density cholesterol, and blood 
pressure. MVPA and CRF were assessed by accelerometry and the 20-meters shuttle run test, 
respectively. Body composition was measured by Dual-energy X-ray absorptiometry. Results: 
in model 1 (adjusted for sex, years from peak high velocity, stature and lean mass), MHO 
children had significantly higher aBMD in total body less head (Cohen´s d effect size, 
ES=0.34), trunk (ES=0.43) and pelvis (ES=0.33), than MUO children. These differences were 
attenuated once MVPA was added to the model 1 (model 2), and most of them disappeared 
once CRF was added to the model 1 (model 3). Conclusions: This novel research shows that 
MHO children have greater aBMD than their MUO peers. Furthermore, both MVPA and more 






About 200 million people suffer osteoporosis worldwide (1) and approximately 3.4 million 
people died because of overweight and obesity (2), and its prevalence is expected to increase. 
As in osteoporosis (3), obesity in childhood tracks into adulthood (4), and therefore, the 
importance of focusing on this population. Obesity and osteoporosis are different disorders 
seldom found in the same individual, but scientific evidence supports a controversial link 
between fat and bone. It has traditionally been considered that excess weight due to obesity has 
a positive effect on bone mineral density (BMD), which may decrease osteoporotic fracture 
risk (5); nevertheless, more recent findings suggest that BMD is compromised (6). From a 
mechanistic point of view, obese youngsters may have greater BMD than their normoweight 
peers due to their greater lean mass and the higher impact associated with it, consequence of 
the extra body weight they have to carry on their everyday life activities (7). However, evidence 
also suggests a negative association between abdominal adiposity and BMD in obese 
youngsters (8). This may be explained by the role of the abdominal adipose tissue in the release 
of adipokines into the bloodstream which negatively affects bone remodelling (8). 
 
Also, childhood obesity is commonly associated with increased risk of cardiovascular and 
metabolic factors (9). Nevertheless, some obese individuals do not show any of these metabolic 
disorders and they are named as metabolically healthy but obese (MHO) (10). MHO 
individuals despite having a body mass index (BMI) ≥30 kg/m2, present a normal/healthy 
metabolic and inflammation profile (11), and may represent for 30% of the obese population 
(10). Previous researches have shown that MHO adolescents and adults have better 
cardiorespiratory fitness (CRF) (12,13) and they are more active (14) than their metabolically 
unhealthy obese (MUO) peers, which was confirmed in a recent meta-analysis (15). Moreover, 
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adolescents with good cardiorespiratory fitness (CRF) have more bone mass than those with 
poor CRF (16) and those more active also present greater levels of bone mass (17). However, 
whether MHO children and adolescents have greater or lower bone mass than their MUO peers 
and whether moderate-to-vigorous physical activity (MVPA) or CRF contribute to these 
differences, has yet to be elucidated. In this regard, MVPA refers to a lifestyle behaviour while 
CRF refers to a physical state derived from a genetic component. Therefore, testing their 
independent contribution is necessary.  
 
So far, the only study published examining the association between MHO and MUO with BMD 
(in adult population) showed that the MUO phenotype was associated with higher total BMD 
than the MHO, but no association was found with lumbar spine BMD (11). Thereby, there 
could be a novel link between BMD and MHO/MUO phenotype. To the best of our knowledge, 
there is no scientific evidence about this possible link in young population. Thus, the aim of 
the present study was two-fold: 1) to examine whether areal bone mineral density (aBMD) 





The present cross-sectional study was developed in a subsample of 188 overweight and obese 
children (10.4 ± 1.2 years old) with valid data in the variables of interest. Both the ActiveBrains 
and EFIGRO studies were developed from 2014 to 2017, under the same protocols and with 





Briefly, ActiveBrains (ClinicalTrials.gov ID´s: NCT02295072) is a randomized controlled trial 
designed to examine the effects of an exercise program on brain, cognitive and academic 
performance, as well as on selected physical and mental health outcomes in overweight/obese 
children (18). A total of 110 overweight/obese children aged 8-11 years were recruited from 
Granada (south of Spain) according to the following inclusion criteria (18): 1) to be overweight 
or obese based on World Obesity Federation (formerly named International Obesity Task 
Force) cut-off points 2) to be 8 to 11 years-old, 3) not to have any physical disabilities or 
neurological disorder that affects their physical performance, and 4) in the case of girls, not to 
have started the menstruation at the moment of the assessments. EFIGRO (ClinicalTrials.gov 
ID´s: NCT02258126) is a randomized controlled trial designed to evaluate the effect of a 
multidisciplinary intervention program on hepatic fat fraction, cardiometabolic risk factors, 
self-esteem and well-being in overweight or obese children (19). A total of 116 
overweight/obese children aged 9-11 years were recruited from Vitoria-Gasteiz (north of 
Spain) according to the following inclusion criteria (19): 1) primary overweight or obesity 
status defined according to the International Obesity Task Force 2) aged between 9 and 11 
years, 3) to have at least one parent or caregiver willing to participate in the program sessions, 
4) not to have medical conditions or medications that would affect study results or limit 
physical activity, and 5) in the case of girls, not to have started the menstruation at the moment 
of the assessments.  
 
The research was conducted according to the Declaration of Helsinki and the protocols were 
approved by the Review Committee for Research Involving Human Subjects at the University 
of Granada and the Ethic Committee of Clinical Investigation of Euskadi. Informed consent 






Weight (kg) and stature (cm) were measured with an electronic scale (SECA 861 and 760, 
Hamburg, Germany) and a stadiometer (SECA 225 and 220, Hamburg, Germany), 
respectively. BMI was calculated as: weight (kg)/stature (m2), and classified into BMI 
categories (overweight and obesity), according to Cole and Lobstein (20) cut-offs. Years from 
peak height velocity (PHV) was used as a maturational landmark, and was predicted through 
age and stature using validated algorithms in boys and girls (21).  
 
Physical activity was objectively measured by tri-axial accelerometers (GT3X+, 
ActiGraph,Pensacola, FL, USA) for seven consecutive days. The participants wore the 
accelerometers on the non-dominant wrist during 24 hours a day and removed it only while 
bathing or swimming. Accelerometer raw data was processed using the GGIR package for R 
(GGIR Package, v.1.5.-24, https://cran.r-project.org/web/packages/GGIR/). In brief, raw data 
was aggregated as the Euclidean Norm Minus One g (ENMO) over 5 second epochs with all 
negative values rounded to 0. The ENMO metric was used to determine the time spent in 
MVPA by applying previously proposed cut-points validated against metabolic equivalents 
(measured with indirect calorimetry) for MVPA (22). 
 
CRF was assessed by the 20 m shuttle run test from the ALPHA (Assessing Levels of Physical 
fitness and Health in Adolescents) test battery, which has been shown to be valid, reliable, 
feasible, and safe for the assessment of health-related physical fitness in children (23). The last 




Fat mass (%), lean mass (kg), and aBMD (g/cm2) were measured by Dual-energy X-ray 
absorptiometry (DXA) using the Hologic QDR 4500W (EFIGRO study) and the Discovery Wi 
(ActiveBrains study) (both from the manufacturer Hologic Series Discovery QDR, Bedford, 
MA, USA). The total body scan was used to obtain aBMD of the total body less head (TBLH), 
trunk, lumbar spine, arms, legs, and pelvis. All DXA scans and analyses were performed using 
the GE encore software (version 4.0.2) and were completed following the same protocol by the 
same researcher within each study, following recommendations from the International Society 
of Clinical Densitometry (24). Data from DXA scans were normalized separately within each 
study and then data were combined.  
 
Briefly, serum triglycerides (mmol/L), fasting glucose (GL, mmol/L), and HDL (mmol/L) 
cholesterol were measured from fasting blood samples using standard protocols. Venepuncture 
was performed to obtain blood samples and those were immediately centrifuged, aliquoted 
within one hour after collection and stored at -70 ºC or below. Systolic and diastolic blood 
pressure was obtained with an automatic oscillometric device (Omron M6, The Netherlands). 
 
We followed the metabolic syndrome definition proposed by Ortega et al. (9) and the cut-off 
points reported by Jolliffe and Janssen (25) linked to the International Diabetes Federation 
adult criteria and Adult Treatment Panel III (25). Participants who did not have any of the 
following cardiometabolic risk factors altered were classified as MHO: high triglycerides levels 
(>1.44 and >1.60 mmol/L in boys and girls, respectively), high fasting glucose levels (>5.60 
mmol/L), low HDL cholesterol (<1.13 and <1.25 mmol/L in boys and girls, respectively) and 
elevated systolic (>121 mmHg) or diastolic (>76 and >80 mmHg in boys and girls, 
respectively) blood pressure. Accordingly, MUO were those who had one or more of these 
cardiometabolic risk factors altered. Waist circumference was excluded as a risk factor 
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following previous literature (12,14) since overweight and obese individuals usually present a 





All statistical analyses were performed using SPSS version 20.0 for Windows (IBM Corp, New 
York, USA), and the significance level was set at p<0.05. Data are presented for overweight 
and obese children. Descriptive analyses were performed by using independent samples T-test 
to detect differences between MHO and MUO within each study (ActiveBrains and EFIGRO). 
 
Analysis of covariance (ANCOVA) was used to examine differences in normalised (Blom’s 
transformation) aBMD between MHO and MUO phenotypes. Sex, years from PHV, stature 
and TBLH lean mass (normalised) were used as covariates (model 1). The contribution of 
MVPA, or CRF was tested in additional models (models 2, and 3, respectively). The effect size 
(ES, Cohen’s d) on aBMD between MHO and MUO with 1 cardiometabolic risk factor or with 
2 or more cardiometabolic risk factors, using the same models of covariates described above is 
shown. The interpretation of ES is: 0.2 small, 0.5 medium and 0.8 large (26).  
 
The selection of the covariates was based on the association with the outcome and exposure 
variables. Sensitivity analyses including sedentary time, vitamin D and dietary calcium intake 
were done (exploratory analysis). These variables did not have influence in the outcome 
variables, so they were not included as part of the models. Finally, complementary information 






The descriptive characteristics of the MHO and MUO children within each study are shown in 
Table 1. In the ActiveBrains study, 50.6% of the participants did not present any metabolic risk 
factors, 28.4% presented one and 21% presented at least two. In the EFIGRO study, 54.2% of 
the participants did not present any metabolic risk factor, 34.6% presented one and 11.2% 
presented two. Overall, MUO children weighed more and, had more BMI, fat mass, waist 
circumference and triglycerides; and lower HDL cholesterol, levels of MVPA and CRF than 
MHO children (all p<0.05). In addition, MUO from the EFIGRO study were more mature and 
older and, had higher glucose levels and lean mass than MHO (all p<0.05). Finally, aBMD did 
not differ between MHO and MUO children within each study. 
 
Adjusted normalised values in aBMD between MHO and MUO overweight/obese children  
 
Table 2 shows a comparison of the adjusted normalised values in aBMD between MHO and 
MUO. In model 1, MHO children had higher aBMD in TBLH (ES=0.34; p=0.026), trunk 
(ES=0.43; p=0.005) and pelvis (ES=0.33; p=0.029), compared to MUO children. Most 
differences remained significant after MVPA was added as a new covariate (model 2). 
Interestingly, most significant differences shown in model 1 disappeared once CRF was 
accounted for (model 3), except for trunk aBMD (ES=0.37; p=0.016).  
 
In an attempt to find out whether differences in aBMD were related with the number of 
cardiometabolic risk factors altered, MUO children were split into two different groups (1 vs. 
≥2 cardiometabolic risk factors) and compared against MHO children. Then, the ES in aBMD 
between MHO, MUO with 1 cardiometabolic risk factor and MUO with ≥2 cardiometabolic 
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risk factors were obtained (Figure 1). Taking MHO as the reference group, generally all ES 
negatively increased from MUO with 1 cardiometabolic risk factor to MUO with 2 or more 
cardiometabolic risk factors (model 1). This trend remained similar but with smaller ES when 
MVPA (model 2) or CRF (model 3) was added into the model. The ES change (model 2 - 
model 1) explained by the contribution of MVPA ranged from 0.00 to 0.01 in participants with 
1 cardiometabolic risk factor and from 0.04 to 0.11 in participants with ≥2 cardiometabolic risk 
factors. Finally, the ES change (model 3 - model 1) explained by the contribution of CRF 
ranged from 0.06 to 0.14 in participants with 1 cardiometabolic risk factor and  from 0.05 to 
0.18 in participants with ≥2 cardiometabolic risk factors. 
 
Sensitivity analysis only with obese children  
 
Descriptive characteristics only for obese participants are shown in supplementary Table 1. 
Overall, MUO children had higher levels of triglycerides and lower HDL cholesterol (all 
p<0.05) in both studies. In addition, MHO children from the ActiveBrains study spent more 
time in MVPA than their MUO peers (p<0.05). Moreover, MHO children from the EFIGRO 
were less mature than MUO children (p<0.05). Adjusted normalised values in aBMD 
(supplementary Table 2) showed that MHO children had higher trunk aBMD (ES=0.34, 
p=0.025) in model 1, compared to MUO children. The addition of MVPA as a covariate (model 
2) did not alter these differences. Finally, the significant differences in trunk BMD disappeared 






To the best of our knowledge, this is the first study reporting differences in aBMD in children 
with MHO and MUO metabolic profiles. Our findings indicate that 1) MHO children have 
greater aBMD in TBLH, trunk and pelvis than MUO children and, 2) MVPA and more 
importantly, CRF seems to partially explain these differences between groups. The ES of the 
differences observed between MHO and MUO ranged from 0.11 and 0.43, suggesting a small 
to medium effect size. Large effect sizes would have been unexpected due to the multifactorial 
aetiology of bone and fat status. 
 
We found only one study examining the association between metabolic profiles and aBMD, 
and it was carried out in adults (11). The authors concluded that there could be a link between 
MHO/MUO phenotypes and aBMD, since MUO adults had better bone status at hip site than 
MHO (11). Albeit in adult population, their findings contradict those observed in our study 
with children, in which MHO children had better BMD. Both studies are difficult to compare 
as not only the target population is different, but also different confounding variables are taken 
into account, which may importantly influence the findings. The study by Mirzababaei et al. 
(11) used age, sex, and BMI as covariates, while a more complete set of confounding variables 
was used in the present study, such as sex, years from PHV, stature and TBLH lean mass 
(model 1). In this regard, the use of BMI as a confounder of bone mass is debatable. BMI is 
calculated using weight and stature where weight is consisting primarily of fat and lean mass. 
It is a well-known that lean mass is the strongest determinant of bone parameters in young 
population (27), as the development of the muscles produces a higher tension on the bones 
following the mechanostat theory (28). However, the association between fat and bone mass is 
debated (6). A study has shown that the association between fat and bone mass disappears once 




Additionally, objectively measured MVPA was additionally taken into account in our study 
(model 2) whose role is clear in the development and maintenance of bone mass (29), and  is 
positively associated with better cardiometabolic risk factor profiles in children and adolescents 
(30). In agreement with our findings, a previous study concluded that MVPA was higher in 
MHO adolescents compared to MUO adolescents, both in the group with overweight/obese 
and only obese (14). However, Camhi et al. (31) did not find significant differences in MVPA 
between MHO and MUO adolescents with obesity. These discrepancies may be due to the use 
of different methods to measure physical activity (objective vs subjective). Even so, due to the 
time spent in MVPA is considered a protective factor of cardiometabolic risk factors during 
youth (14), using MVPA as a covariate in the association between bone mass and metabolic 
profiles is recommended. This is supported by our data showing greater ES changes explained 
by the contribution of MVPA in participants with ≥2 cardiometabolic risk factors than in those 
with 1 cardiometabolic risk factor.  
 
Importantly, we also took into account the effect of CRF (model 3) because of its association 
both with metabolic profiles (12,13,32), and bone parameters (16,33). In our study, the role of 
CRF is evident from the change in the ES already observed in participants with just 1 
cardiometabolic risk factor. Recently published reviews and updates concluded that a better 
CRF was considered a characteristic of the MHO individuals and, it is considered a paramount 
in the prognosis of MHO adults and children (13,15). However, a study published in youth, 
showed no significant differences in CRF between metabolic profiles (14). Of note, differences 
in bone parameters have been reported according to fitness levels in adolescents, with those 
with better CRF having greater BMC in the whole body and extremities than those with poorer 
CRF (16). Therefore, CRF could be considered a predictor of aBMD in youth (34) and its use 




With this in mind, the association between the MHO and MUO phenotypes with CRF and as a 
consequence with bone parameters, may be due to the known association between CRF with 
some of the cardiometabolic risk factors, i.e., HDL and triglycerides (35), peculiar of the 
aforementioned metabolic profiles. In our study, CRF was positively associated with HDL and 
negatively associated with triglycerides (r=0.27 and -0.20 respectively, data not shown), which 
agrees with the only study published with MHO/MUO in European adolescents (32). In 
addition, changes in CRF were negatively correlated with changes in triglycerides and 
HDL/total cholesterol ratio in adolescents, even after controlling for age, gender, fat-free mass 
and pubertal status (36). Also, young adults with high CRF (≥60th percentile) showed lower 
triglycerides levels and higher HDL levels compared to young adults with low CRF (<20th 
percentile) (37). In this regard, CRF seems to explain the link between metabolic profiles 
(MHO and MUO) and aBMD in our study with children. 
 
Furthermore, our findings may be explained through the bone-regulating role of hormones and 
nutrients. A novel study showed that MHO adults had higher serum concentrations of ionized 
magnesium, dietary magnesium intakes, and serum osteocalcin while lower serum PTH 
compared to MUO adults (38). Magnesium, together with the thyroid and parathyroid glands 
support bone health by stimulating the production of calcitonin, known to act as a bone-
preserving hormone and regulating PTH (39). It is well known that PTH regulates serum 
calcium through its effects on bone, kidney, and the intestine (39). In bone, PTH enhances the 
release of calcium from the large reservoir and leads to bone resorption (39). 
 
Some limitations of this study deserve to be commented. Firstly, the results cannot establish a 
cause-effect relationship due to its cross-sectional design. Secondly, supplementary material 
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data have been obtained using a relatively small sample of obese children (MHO =54 and 
MUO=69) and, therefore, some of the differences between MHO and MUO are non-significant 
but borderline. Thirdly, despite the fact that physical activity was objectively measured by tri-
axial accelerometers, the obtained data may be affected by various factors and generally 
produce greater errors than those observed for physical fitness (40). Fourthly, data from 
observational studies generally show a stronger association between fitness and health 
parameters than for physical activity and health parameters (40). This might also explain why 
MVPA did not affect the association between bone parameters and metabolic profile to the 
same extent than CRF.  
 
In conclusion, this novel research shows that MHO children have greater aBMD than their 
unhealthy peers (MUO). Furthermore, both MVPA and more importantly CRF, seem to 
partially explain these differences. Taking into account that children are in a very sensitive 
period to changes, further longitudinal studies such as clinical trials and cohort studies are 
needed. These types of studies would allow a better understanding of the development of bone 
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Figure 1. Adjusted differences on aBMD (g/cm2) between MHO (as reference, n=99) and 
MUO with 1 (n=60) or with 2 or more cardiometabolic risk factors (n=29). Model 1 adjusted 
for sex, years from PHV, stature and TBLH lean mass (normalised); Model 2 for model 
1+MVPA; and Model 3 for model 1+CRF.  
 
